AzTrials
AzTrials

Postoperative Pain After Total Knee ArthroplastyNCT07457814

Postoperative Pain and Analgesic Use After Total Knee Arthroplasty

An observational study of Postoperative Pain After Total Knee Arthroplasty and Postoperative Pain, run by Tomas Bata Hospital, Czech Republic at 1 site in Czechia.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective observational study evaluates postoperative pain intensity and analgesic consumption in patients undergoing total knee arthroplasty (TKA) under different anesthesia techniques. Read more about this study

Who is it for?
Ages 18 to 100 yearsHealthy volunteers can take part
Type of treatment
Injection or infusion
How many people
50 participants
Where
1 siteCzechia
Study dates
1 Mar 2026to 15 Jun 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Adult patients aged 18-100 years undergoing primary total knee arthroplasty at Krajská nemocnice T. Bati, a. s. Patients must have ASA physical status I-III, GCS 15, ability to understand the study procedures, and provide informed consent. Only patients capable of cooperation during pre-anesthetic evaluation and without severe sensory impairment are included.

Who may be able to join

  • Age 18-100 years
  • Primary total knee arthroplasty (TKA)
  • ASA physical status I-III
  • Glasgow Coma Scale (GCS) score of 15
  • Ability to understand study procedures and provide informed consent
  • Ability to cooperate during pre-anesthetic evaluation
  • No severe sensory impairment (e.g., blindness, deafness)

Who cannot join

  • Revision or reoperation of TKA
  • ASA score IV or higher
  • Refusal to participate or inability to provide informed consent
  • GCS ≤ 14
  • Limited legal capacity
  • Active psychiatric disorder
Show all 10Show fewer
  • Chronic use of strong opioid analgesics
  • Neurological disease affecting pain perception or cooperation
  • Cognitive impairment or language barrier preventing questionnaire completion
  • Use of anesthesia techniques other than GA + PNB or SA + PNB (e.g., epidural anesthesia, local infiltration without PNB)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Klára Nekvindová, MD, Ph.D. contact

+420 577 552 111

nekvindova.klara@gmail.com

Czechia1 site
  • Tomas Bata regional hospital

    Zlín, 76001

    Klára Nekvindová, MD, Ph.D., +420 577 552 111

Other trials in Czechia

About this study

Official title: Postoperative Pain and Analgesic Consumption in Patients Undergoing Total Knee Arthroplasty Under General Anesthesia With Peripheral Nerve Block Versus Spinal Anesthesia With Peripheral Nerve Block

This prospective observational study evaluates postoperative pain intensity and analgesic consumption in patients undergoing total knee arthroplasty (TKA) under different anesthesia techniques. Patients receive either general anesthesia with peripheral nerve block, spinal anesthesia with peripheral nerve block, spinal anesthesia alone, or general anesthesia with an epidural catheter. Pain scores (NRS), analgesic use, adverse effects, patient satisfaction, and the need for therapeutic interventions are assessed during the first 48 hours after surgery. The study aims to identify differences in postoperative pain control and factors associated with hypotension and other complications.

Read the detailed description

This prospective, monocentric observational study evaluates postoperative pain intensity and analgesic consumption in adult patients undergoing primary total knee arthroplasty (TKA). The study focuses on anesthesia techniques routinely used in clinical practice, including general anesthesia with peripheral nerve block, general anesthesia with an epidural catheter, spinal anesthesia with peripheral nerve block, and spinal anesthesia alone.

The primary methodological aim is to compare postoperative pain trajectories (NRS) and total analgesic use during the first 48 hours after surgery across anesthesia strategies. Secondary observations include adverse effects related to analgesia, patient satisfaction, and the need for therapeutic interventions such as fluid administration, vasopressors, antiemetics, or adjustments in analgesic regimen.

Independent variables include type of anesthesia, ASA physical status, age, sex, BMI, type of peripheral nerve block, and duration of surgery. Dependent variables include postoperative pain scores, analgesic consumption, adverse events, and patient-reported satisfaction.

The study is designed to identify clinically relevant differences in postoperative pain control and to explore factors associated with hypotension and other perioperative complications. Findings may support optimization of perioperative analgesia and guide clinical decision-making in anesthesia management for TKA.

Keywords
Total Knee Arthroplasty, Postoperative Pain, Anesthesia Techniques, Analgesic Consumption, Epidural Analgesia, Opioid Use, General Anesthesia, Spinal Anesthesia, Pain Management
Medical subject headings
Pain, Postoperative, Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07457814
Study groupRoleWhat they receive
General Anesthesia + Peripheral Nerve Block (CA + PNB)Patients undergoing total knee arthroplasty under general anesthesia combined with a peripheral nerve block. General anesthesia is induced using intravenous and inhalational agents. A peripheral nerve block (most commonly femoral or saphenous) is administered preoperatively to reduce postoperative pain and opioid requirements. This group represents a commonly used multimodal analgesic approach in routine clinical practice.
General Anesthesia + Epidural Catheter (CA + EDA)Patients undergoing total knee arthroplasty under general anesthesia with an epidural catheter placed for intraoperative and postoperative analgesia. General anesthesia is induced using intravenous and inhalational agents. The epidural catheter allows continuous administration of analgesics and individualized dose adjustment to maintain postoperative pain control. This group represents a commonly used technique for providing extended regional analgesia following TKA.
Spinal Anesthesia + Peripheral Nerve Block (SA + PNB)Patients undergoing total knee arthroplasty under spinal anesthesia supplemented with a peripheral nerve block. Spinal anesthesia is administered into the subarachnoid space to provide intraoperative analgesia. A peripheral nerve block (femoral or saphenous) is added to enhance postoperative pain control and reduce the need for systemic analgesics. This combination represents a commonly used multimodal analgesic strategy.
Spinal Anesthesia (SA)Patients receiving spinal anesthesia alone without an additional peripheral nerve block. Spinal anesthesia provides sensory and motor blockade of the lower body during surgery. This group allows evaluation of postoperative pain and analgesic requirements in patients managed with spinal anesthesia as the sole regional technique.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative pain intensity

    Pain intensity will be assessed using the Visual Analog Scale (VAS) or Numerical Rating Scale (NRS) at predefined postoperative intervals. Both scales range from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable.

    Higher scores represent worse pain intensity.

    Measured: 6 hours, 24 hours, and 48 hours after surgery

Secondary outcomes (5)
  1. Analgesic consumption

    Total opioid and non-opioid analgesic dose administered within 48 hours postoperatively.

    Measured: First 48 hours after surgery

  2. Adverse effects

    Incidence of nausea, vomiting, urinary retention, hypotension, and other analgesia-related adverse events.

    Measured: First 48 hours after surgery

  3. Patient satisfaction

    Patient satisfaction with pain control and overall care will be assessed using a 5-point Likert scale, ranging from 1 to 5, where 1 indicates very low satisfaction and 5 indicates very high satisfaction. Higher scores represent better satisfaction.

    Measured: 48 hours after surgery

  4. Length of hospital stay

    Length of hospital stay will be measured as the number of days from the date of surgery until the date of hospital discharge

    Measured: From the day of surgery (Day 0) through hospital discharge (typically 3-14 days).

  5. Number of participants requiring therapeutic interventions

    The need for therapeutic interventions will be recorded, including additional analgesia, intravenous fluids, vasopressors, or other supportive measures administered due to insufficient pain control or hemodynamic instability.

    Measured: Up to 48 hours after surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Mar 2026
  2. Study start1 Mar 2026 (estimated)
  3. Primary completion1 Mar 2027 (estimated)
  4. Study completion15 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07457814
Sponsor's protocol ID
2026-01
Status last verified
Mar 2026
First submitted
24 Feb 2026
Last updated
9 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: "Individual participant data will not be shared because the study involves sensitive clinical information and no data-sharing plan was included in the ethics committee approval. Data will be used exclusively for the purposes of this study."

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Pain After Total Knee Arthroplasty and Postoperative Pain, run by Tomas Bata Hospital, Czech Republic at 1 site in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 9 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Klára Nekvindová, MD, Ph.D. (+420 577 552 111, nekvindova.klara@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative pain intensity (time frame: 6 hours, 24 hours, and 48 hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in